...BRCA1 and BRCA2, respectively. The ovarian cancer SIR was 12.38 (3.1-49.51) for BRCA1 and the prostate cancer SIR was 18...
...BRCA1 is a well-known player in the etiology of breast cancer. While familial breast cancer is often marked by BRCA1 mut...
...BRCA1 exon 5-7 deletion with a novel breakpoint, a BRCA1 exon 13 duplication, a BRCA1 exon 17-19 deletion, a BRCA1 exon ...
...BRCA1/2-negative or untested families. After a systematic literature search seven models were selected: Gail-2, Claus Mo...
Findings in BRCA1 mutation carriers suggest that physical activity, particularly during childhood, may be linked to a re...
...BRCA1 in the breast where somatic mutations of BRCA1 are rare. To better understand breast cancer etiology and progressi...
...BRCA1 or BRCA2 mutation carriers, we undertook a multi-center study of 3,442 BRCA1 and 2,095 BRCA2 mutation carriers.,We...
...BRCA1 and BRCA2 carriers (adjusted hazard ratio (HR) 0.72 (95% CI = 0.53-0.99; P = 0.04 for BRCA1, HR 1.47 (95% CI = 0.9...
...BRCA1-related breast cancers. We hypothesized that the rule also might not apply in basal-like breast cancers (BLBC), an...
...BRCA1 and 31 in BRCA2). Notably, many mutations are novel (13 of the 30 BRCA1 mutations and 24 of the 44 BRCA2). We repo...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
